Redefining Pathologic Complete Response through Standardized Assessment and Molecular Surveillance in Esophageal Squamous Cell Carcinoma
Letter  ·  Published: 08 April 2026
Issue cover
Oncology Communications
Volume 1, Issue 1, 2026: 43-44
Letter Open Access

Redefining Pathologic Complete Response through Standardized Assessment and Molecular Surveillance in Esophageal Squamous Cell Carcinoma

1 Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China
2 Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China
3 Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China
* Corresponding Authors: Feng Li, [email protected]; Jian Zeng, [email protected]
Volume 1, Issue 1

Article Information

Pages 43-44

Abstract

This is a Letter discussing a recently published article.

Keywords

Esophageal squamous cell carcinoma Pathologic complete response Letter

Data Availability Statement

Not applicable.

Funding

This work was supported without any funding.

Conflicts of Interest

The authors declare no conflicts of interest.

AI Use Statement

The authors declare that no generative AI was used in the preparation of this manuscript.

Ethical Approval and Consent to Participate

Not applicable.

References

  1. Yuan, C., Chen, C., Liu, Z., Tan, L., Li, Y., Tian, Z., ... & Liu, Z. (2026). Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified management. The Journal of Thoracic and Cardiovascular Surgery.
    [CrossRef] [Google Scholar]
  2. Deutsch, J. S., Scolyer, R. A., Burton, E., Busam, K. J., Chen, K. Y., Cimino-Mathews, A., ... & SITC and INMC. (2026). Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort. Annals of Oncology, 37(2), 141-154.
    [CrossRef] [Google Scholar]
  3. Cote, R. J. (2003). Occult metastases: real harm or false alarm? The Journal of Thoracic and Cardiovascular Surgery, 126(2), 332-333.
    [CrossRef] [Google Scholar]
  4. Liu, Z., Wang, G., Yang, Y., Su, Y., Zhang, H., Liu, J., ... & Liu, Z. (2025). ctDNA detects residual disease after neoadjuvant chemoradiotherapy and guides adjuvant therapy in esophageal squamous cell carcinoma. Cell Reports Medicine, 6(9), 102334.
    [CrossRef] [Google Scholar]

Cite This Article

APA Style
Pan, Y., Li, F., & Zeng, J. (2026). Redefining Pathologic Complete Response through Standardized Assessment and Molecular Surveillance in Esophageal Squamous Cell Carcinoma. Oncology Communications, 1(1), 43–44. https://doi.org/10.62762/OC.2026.701176
Export Citation
RIS Format
Compatible with EndNote, Zotero, Mendeley, and other reference managers
TY  - JOUR
AU  - Pan, Yang
AU  - Li, Feng
AU  - Zeng, Jian
PY  - 2026
DA  - 2026/04/08
TI  - Redefining Pathologic Complete Response through Standardized Assessment and Molecular Surveillance in Esophageal Squamous Cell Carcinoma
JO  - Oncology Communications
T2  - Oncology Communications
JF  - Oncology Communications
VL  - 1
IS  - 1
SP  - 43
EP  - 44
DO  - 10.62762/OC.2026.701176
UR  - https://www.icck.org/article/abs/OC.2026.701176
KW  - Esophageal squamous cell carcinoma
KW  - Pathologic complete response
KW  - Letter
AB  - This is a Letter discussing a recently published article.
SN  - 3142-8894
PB  - Institute of Central Computation and Knowledge
LA  - English
ER  - 
BibTeX Format
Compatible with LaTeX, BibTeX, and other reference managers
@article{Pan2026Redefining,
  author = {Yang Pan and Feng Li and Jian Zeng},
  title = {Redefining Pathologic Complete Response through Standardized Assessment and Molecular Surveillance in Esophageal Squamous Cell Carcinoma},
  journal = {Oncology Communications},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {43-44},
  doi = {10.62762/OC.2026.701176},
  url = {https://www.icck.org/article/abs/OC.2026.701176},
  abstract = {This is a Letter discussing a recently published article.},
  keywords = {Esophageal squamous cell carcinoma, Pathologic complete response, Letter},
  issn = {3142-8894},
  publisher = {Institute of Central Computation and Knowledge}
}

Article Metrics

Citations
Crossref
0
Scopus
0
Views
349
PDF Downloads
141

Publisher's Note

ICCK stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and Permissions

CC BY Copyright © 2026 by the Author(s). Published by Institute of Central Computation and Knowledge. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
Oncology Communications
Oncology Communications
ISSN: 3142-8894 (Online)
Portico
Preserved at
Portico